Principal Financial Group Inc Celldex Therapeutics, Inc. Transaction History

Principal Financial Group Inc

  • $160 Billion
  • Q2 2024

A detailed history of Principal Financial Group Inc transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 10,572 shares of CLDX stock, worth $359,130. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,572
Previous 13,153 19.62%
Holding current value
$359,130
Previous $552,000 29.17%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024
SELL
$32.76 - $42.56 $84,553 - $109,847
-2,581 Reduced 19.62%
10,572 $391,000
Q1 2024

Apr 29, 2024
BUY
$35.22 - $51.88 $42,052 - $61,944
1,194 Added 9.98%
13,153 $552,000
Q4 2023

Feb 07, 2024
SELL
$22.61 - $40.65 $20,100 - $36,137
-889 Reduced 6.92%
11,959 $474,000
Q3 2023

Nov 02, 2023
BUY
$25.45 - $37.46 $38,098 - $56,077
1,497 Added 13.19%
12,848 $353,000
Q2 2023

Aug 07, 2023
SELL
$30.29 - $38.28 $21,081 - $26,642
-696 Reduced 5.78%
11,351 $385,000
Q1 2023

May 09, 2023
BUY
$34.78 - $47.43 $48,483 - $66,117
1,394 Added 13.09%
12,047 $433,000
Q4 2022

Feb 09, 2023
BUY
$27.78 - $45.38 $3,000 - $4,901
108 Added 1.02%
10,653 $474,000
Q3 2022

Nov 09, 2022
BUY
$22.7 - $37.57 $43,288 - $71,645
1,907 Added 22.08%
10,545 $297,000
Q2 2022

Aug 10, 2022
SELL
$20.5 - $37.33 $693,945 - $1.26 Million
-33,851 Reduced 79.67%
8,638 $233,000
Q1 2022

May 09, 2022
SELL
$27.64 - $39.32 $417,750 - $594,282
-15,114 Reduced 26.24%
42,489 $1.45 Million
Q4 2021

Feb 09, 2022
SELL
$35.68 - $56.27 $1.28 Million - $2.02 Million
-35,825 Reduced 38.35%
57,603 $2.23 Million
Q3 2021

Nov 09, 2021
BUY
$28.95 - $55.99 $276,848 - $535,432
9,563 Added 11.4%
93,428 $5.04 Million
Q2 2021

Aug 10, 2021
BUY
$20.71 - $35.37 $1.74 Million - $2.97 Million
83,865 New
83,865 $2.8 Million

Others Institutions Holding CLDX

# of Institutions
195
Shares Held
63.4M
Call Options Held
206K
Put Options Held
176K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.59B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email